| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 12, 2021 | Sell(S) | 339K | $2.23 | $756K | 5.4M |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-21-007592) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for VYNE Therapeutics Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.